Wei-Che Hung1, Hui-Chen Cheng1,2,3,4,5, An-Guor Wang6,7. 1. Department of Ophthalmology, Taipei Veterans General Hospital, 201 Sec. 2, Shih-Pai Rd., Taipei, 11217, Taiwan. 2. Department of Ophthalmology, School of Medicine, National Yang Ming Chiao Tung University, Taipei, Taiwan. 3. Program in Molecular Medicine, College of Life Sciences, National Yang Ming Chiao Tung University, Taipei, Taiwan. 4. Department of Life Sciences and Institute of Genome Sciences, College of Life Sciences, National Yang Ming Chiao Tung University, Taipei, Taiwan. 5. Brain Research Center, National Yang Ming Chiao Tung University, Taipei, Taiwan. 6. Department of Ophthalmology, Taipei Veterans General Hospital, 201 Sec. 2, Shih-Pai Rd., Taipei, 11217, Taiwan. agwang@vghtpe.gov.tw. 7. Department of Ophthalmology, School of Medicine, National Yang Ming Chiao Tung University, Taipei, Taiwan. agwang@vghtpe.gov.tw.
Abstract
BACKGROUND: To report the clinical features of a patient with melanoma-associated retinopathy (MAR) with anti-transient receptor potential cation channel, subfamily M, member 1 (TRPM1) autoantibodies showing concomitant Off-bipolar cell dysfunction. METHODS: We evaluated a patient with a past history of scalp melanoma presented with sudden-onset shimmering photopsia in both eyes. MAR was confirmed with complete ophthalmic examinations, electronegative electroretinogram (ERG), and the presence of anti-TRPM1 autoantibodies by Western blot analysis. S-cone ERG and photopic On-Off ERG were studied in this patient as well. RESULTS: The patient's best-corrected visual acuity was 6/30 in the right eye and 6/8.6 in the left eye. Fundus and OCT findings were unremarkable. Visual field test showed severe constriction in both eyes. His full-field ERG was electronegative. S-cone ERG recorded preservation of L/M-cone-mediated response and undetectable S-cone-mediated response. Photopic On-Off ERG disclosed attenuated On- and Off-response. Western blot analysis confirmed immunoreactivity of the patient's serum to a 30 kDa TRPM1 recombinant protein. Whole-body positron emission tomography scan detected lymph node metastases in the neck. CONCLUSIONS: Anti-TRPM1 autoantibody-positive MAR varies greatly in its presentation and clinical course. We present a case of anti-TRPM1 autoantibody-positive MAR with atypical feature of Off-bipolar cell involvement. A complete electroretinographic study together with identification of the pathogenic antiretinal autoantibodies may help better understand and subclassify the disease in the future.
BACKGROUND: To report the clinical features of a patient with melanoma-associated retinopathy (MAR) with anti-transient receptor potential cation channel, subfamily M, member 1 (TRPM1) autoantibodies showing concomitant Off-bipolar cell dysfunction. METHODS: We evaluated a patient with a past history of scalp melanoma presented with sudden-onset shimmering photopsia in both eyes. MAR was confirmed with complete ophthalmic examinations, electronegative electroretinogram (ERG), and the presence of anti-TRPM1 autoantibodies by Western blot analysis. S-cone ERG and photopic On-Off ERG were studied in this patient as well. RESULTS: The patient's best-corrected visual acuity was 6/30 in the right eye and 6/8.6 in the left eye. Fundus and OCT findings were unremarkable. Visual field test showed severe constriction in both eyes. His full-field ERG was electronegative. S-cone ERG recorded preservation of L/M-cone-mediated response and undetectable S-cone-mediated response. Photopic On-Off ERG disclosed attenuated On- and Off-response. Western blot analysis confirmed immunoreactivity of the patient's serum to a 30 kDa TRPM1 recombinant protein. Whole-body positron emission tomography scan detected lymph node metastases in the neck. CONCLUSIONS: Anti-TRPM1 autoantibody-positive MAR varies greatly in its presentation and clinical course. We present a case of anti-TRPM1 autoantibody-positive MAR with atypical feature of Off-bipolar cell involvement. A complete electroretinographic study together with identification of the pathogenic antiretinal autoantibodies may help better understand and subclassify the disease in the future.
Authors: Anuradha Dhingra; Marie E Fina; Adam Neinstein; David J Ramsey; Ying Xu; Gerald A Fishman; Kenneth R Alexander; Haohua Qian; Neal S Peachey; Ronald G Gregg; Noga Vardi Journal: J Neurosci Date: 2011-03-16 Impact factor: 6.167
Authors: Catherine W Morgans; Jianmei Zhang; Brett G Jeffrey; Steve M Nelson; Neal S Burke; Robert M Duvoisin; R Lane Brown Journal: Proc Natl Acad Sci U S A Date: 2009-10-27 Impact factor: 11.205
Authors: Yin Shen; J Alexander Heimel; Maarten Kamermans; Neal S Peachey; Ronald G Gregg; Scott Nawy Journal: J Neurosci Date: 2009-05-13 Impact factor: 6.167
Authors: A H Milam; J C Saari; S G Jacobson; W P Lubinski; L G Feun; K R Alexander Journal: Invest Ophthalmol Vis Sci Date: 1993-01 Impact factor: 4.799
Authors: Maja Sustar; Graham E Holder; Jan Kremers; Claire S Barnes; Bo Lei; Naheed W Khan; Anthony G Robson Journal: Doc Ophthalmol Date: 2018-06-22 Impact factor: 2.379